Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue |
Lee, Jieun
(Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital)
Cho, Sung-Min (Integrated Research Center for Genome Polymorphism, College of Medicine, The Catholic University of Korea) Kim, Min Sung (Department of Pathology, College of Medicine, The Catholic University of Korea) Lee, Sug Hyung (Department of Pathology, College of Medicine, The Catholic University of Korea) Chung, Yeun-Jun (Integrated Research Center for Genome Polymorphism, College of Medicine, The Catholic University of Korea) Jung, Seung-Hyun (Cancer Evolution Research Center, College of Medicine, The Catholic University of Korea) |
1 | Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res 2012;72:4875-4882. DOI |
2 | Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 2014;32:579-586. DOI |
3 | Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, et al. Use of liquid biopsies in clinical oncology: pilot experience in 168 patients. Clin Cancer Res 2016;22:5497-5505. DOI |
4 | Jung SH, Kim MS, Lee SH, Park HC, Choi HJ, Maeng L, et al. Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. Proc Natl Acad Sci U S A 2016;113:10672-10677. DOI |
5 | O'Leary B, Finn RS, Turner NC. Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol 2016;13:417-430. DOI |
6 | Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, et al. Palbociclib and letrozole in advanced breast cancer. N Engl J Med 2016;375:1925-1936. DOI |